Road Biology Environmental Protection Technology Co., Ltd. (SHA:688156)
China · Delayed Price · Currency is CNY 26.79
+0.66 (2.53%)
At close: May 28, 2026
SHA:688156 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 429.75 | 380.21 | 260.19 | 341.44 | 340.34 | 380.34 |
Other Revenue | - | - | 17.42 | 9.63 | 1.74 | 1.66 |
| 429.75 | 380.21 | 277.62 | 351.08 | 342.08 | 382 | |
Revenue Growth (YoY) | 57.57% | 36.95% | -20.92% | 2.63% | -10.45% | 52.56% |
Cost of Revenue | 21.9 | 304.43 | 218.66 | 224.19 | 222.82 | 240.75 |
Gross Profit | 407.86 | 75.77 | 58.96 | 126.88 | 119.26 | 141.25 |
Selling, General & Admin | 0.76 | 78.76 | 74.4 | 51.21 | 45.23 | 39.51 |
Research & Development | 0.7 | 14.67 | 19.76 | 13.65 | 13.51 | 15.95 |
Other Operating Expenses | 462.42 | 4.82 | 4.36 | 3.53 | 2.03 | 1.75 |
Operating Expenses | 462.82 | 98.25 | 130.68 | 95.42 | 77.34 | 64.39 |
Operating Income | -54.96 | -22.48 | -71.73 | 31.46 | 41.92 | 76.86 |
Interest Expense | -0.06 | - | -11.73 | -6.79 | -2.14 | -1.38 |
Interest & Investment Income | 0.56 | 0.08 | 2.84 | 5.48 | 9.25 | 8.19 |
Other Non Operating Income (Expenses) | 0.18 | -47.65 | -1.2 | -0.27 | -0.36 | -0.44 |
EBT Excluding Unusual Items | -54.28 | -70.04 | -81.82 | 29.88 | 48.67 | 83.23 |
Gain (Loss) on Sale of Investments | - | - | - | 0.03 | 0.21 | 0.1 |
Gain (Loss) on Sale of Assets | -0.07 | -0.19 | 0.1 | -0 | 0.54 | 1.09 |
Asset Writedown | -2.73 | -7.3 | -0.07 | -0.15 | - | - |
Other Unusual Items | -0.03 | - | 2.99 | 4.1 | 0.46 | 5.24 |
Pretax Income | -57.11 | -77.53 | -78.8 | 33.85 | 49.88 | 89.67 |
Income Tax Expense | 0.86 | -7.6 | -11.8 | 4.23 | 10.67 | 10.34 |
Earnings From Continuing Operations | -57.97 | -69.93 | -67 | 29.63 | 39.21 | 79.33 |
Minority Interest in Earnings | -2.56 | -0.17 | 10.45 | -2.66 | -13.28 | -3.79 |
Net Income | -60.53 | -70.1 | -56.55 | 26.97 | 25.93 | 75.54 |
Net Income to Common | -60.53 | -70.1 | -56.55 | 26.97 | 25.93 | 75.54 |
Net Income Growth | - | - | - | 4.02% | -65.68% | 58.23% |
Shares Outstanding (Basic) | 94 | 100 | 101 | 96 | 93 | 92 |
Shares Outstanding (Diluted) | 94 | 100 | 101 | 96 | 93 | 92 |
Shares Change (YoY) | -13.35% | -0.83% | 4.84% | 4.02% | 0.51% | 23.49% |
EPS (Basic) | -0.64 | -0.70 | -0.56 | 0.28 | 0.28 | 0.82 |
EPS (Diluted) | -0.64 | -0.70 | -0.56 | 0.28 | 0.28 | 0.82 |
EPS Growth | - | - | - | - | -65.85% | 28.13% |
Free Cash Flow | - | -132.06 | -287.95 | -341.8 | -145.72 | -14.48 |
Free Cash Flow Per Share | - | -1.32 | -2.85 | -3.55 | -1.57 | -0.16 |
Dividend Per Share | - | - | - | 0.050 | 0.100 | 0.300 |
Dividend Growth | - | - | - | -50.00% | -66.67% | 50.00% |
Gross Margin | 94.91% | 19.93% | 21.24% | 36.14% | 34.86% | 36.98% |
Operating Margin | -12.79% | -5.91% | -25.84% | 8.96% | 12.25% | 20.12% |
Profit Margin | -14.09% | -18.44% | -20.37% | 7.68% | 7.58% | 19.78% |
Free Cash Flow Margin | - | -34.73% | -103.72% | -97.36% | -42.60% | -3.79% |
EBITDA | - | 50.61 | -25.91 | 66.5 | 68.29 | 101.79 |
EBITDA Margin | - | 13.31% | -9.33% | 18.94% | 19.96% | 26.65% |
D&A For EBITDA | - | 73.09 | 45.82 | 35.04 | 26.37 | 24.94 |
EBIT | -54.96 | -22.48 | -71.73 | 31.46 | 41.92 | 76.86 |
EBIT Margin | -12.79% | -5.91% | -25.84% | 8.96% | 12.25% | 20.12% |
Effective Tax Rate | - | - | - | 12.49% | 21.39% | 11.53% |
Revenue as Reported | 47.05 | - | 277.62 | 351.08 | 342.08 | 382 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.